SEC Form 4 · accession 0001567619-18-006626
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Andrew Douglas
Officer — President and COO ResMed Inc.
Period of report
Nov 15, 2018
Accepted (ET)
Nov 19, 2018 · 3:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Nov 15, 2018 | M | 3,307 | $43.63 | A | 59,112 | D | |
| ResMed Common Stock | Nov 15, 2018 | S | 3,307 | $101.44 | D | 55,805 | D | |
| ResMed Common Stock | Nov 15, 2018 | S | 984 | $101.44 | D | 109,222 | I | Douglas Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF1 | $43.63 | Nov 15, 2018 | M | 3,307 | D | Mar 1, 2014 | Mar 1, 2020 | ResMed Commmon Stock | 3,307 | 36,372 | D |
| ResMed Common Stock OptionsF2 | $101.64 | holding | — | — | — | Nov 11, 2019 | Nov 14, 2025 | ResMed Commmon Stock | 102,975 | 102,975 | D |
Explanation of responses
- F1Represents date options first became exercisable. Options vest 1/3 per year.
- F2Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2019, 2020 and 2021.